Bedrosian Camille L
Director | Chief Medical Officer | EVP And Chief Medical Officer
4 companies
Insider Signal Score
64
GoodTrades Analyzed
13
12M Win Rate
63.6%
Avg 3M Return
+6.4%
Avg 12M Return
-1.1%
Bedrosian Camille L is a Chief Medical Officer at Amylyx Pharmaceuticals, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $7.7M based on current market prices.
Holdings by Company
AMLXDec 1, 2025
Current Shares175.8K
Value$3.84M
Net Activity-47,907
Bought: 0Sold: 47.9K
RAREMar 1, 2023
Current Shares50.6K
Value$1.26M
Net Activity-51,130
Bought: 0Sold: 51.1K
CRNXJun 18, 2026
Current Shares22.2K
Value$1.87M
Net Activity0
Bought: 0Sold: 0
RYTMJun 18, 2025
Current Shares7.0K
Value$775.0K
Net Activity0
Bought: 0Sold: 0
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 6,580 | $14.35 | $94,418.39 | -3.6% | +7.4% | - | |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 12,039 | $14.58 | $175,517.78 | -6.2% | -10.3% | - | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 12,425 | $3.47 | $43,082.45 | -6.0% | +81.1% | +292.7% | |
| Dec 2, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 5,421 | $5.54 | $30,007.40 | -3.8% | -45.9% | +147.7% | |
| Sep 30, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 11,442 | $3.20 | $36,559.48 | -7.4% | +18.5% | +319.4% | |
| Mar 1, 2023 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 3,881 | $45.25 | $175,615.25 | -7.7% | +6.0% | +13.3% | |
| Mar 1, 2022 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 2,821 | $66.62 | $187,935.02 | -7.7% | -30.4% | -32.2% | |
| Jan 30, 2022 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 1,657 | $66.30 | $109,859.10 | -4.3% | +1.1% | -38.5% | |
| Oct 14, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sell | 359 | $81.14 | $29,129.26 | -0.9% | -12.1% | -54.2% | |
| Sep 2, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP And Chief Medical Officer | Sale+OE | 5,000 | $100.11 | $500,525.00 | -6.1% | -24.9% | -52.9% |
Page 1Next →